Apr. 14, 2024
Is Kinase-Specific Drug Discovery Possible?
Tomoya Sugai & Noriki Kutsumura
Chemistry 2024, 79, 72-73. (web)
2024年4月1日
Fiscal year 2024 has started.
Mar. 31, 2024
Mar. 31th The following presentations were made at the 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama).
Tomoka Kazama (B4): Development of comprehensive synthetic method for flavonoids and structure-activity relationship study for salt-inducible kinases
Yuta Koizumi (B4): Development of a novel synthetic route for the KLF5 inhibitor NC114 derivartives
Ruburika Nagao (M2): Design and synthesis of 2,4,5-trisubstituted pyrimidine-centred salt-inducible kinase inhibitor
Kenshiro Nakamura (B4): Development of a Novel Salt-Inducible Kinase Activator
Mar. 26, 2024
Mar. 21th The following presentation was made at the 104th CSJ Annual Meeting (2024).
Mizuki Oyanagi (B4): Development of novel sulfurizing reagents with an adamantane-like structure
Mar. 26th The following presentation was made at Japan Society for Bioscience, Biotechnology, and Agrochemistry, 2024 Annual Meeting.
Dr. Tomoya Sugai: Development of synthetic methods for the construction of flavonoid libraries
Mar. 8, 2024
Mar. 8th A farewell party was held.